lurasidone

(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decan-3,5-dion

(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione

(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-pipérazinyl]méthyl}cyclohexyl]méthyl}-4-azatricyclo[5.2.1.0~2,6~]décane-3,5-dione

367514-87-2

4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-, (3aR,4S,7R,7aS)-

lurasidona

lurasidone

lurasidone

lurasidonum

луразидон

لوراسيدون

鲁拉西酮

(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0²,⁶]decane-3,5-dione

(3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione

(3AR,4S,7R,7AS)-2-[((1R,2R)-2-[[4-(1,2-BENZISOTHIAZOL-3-YL)-PIPERAZIN-1-YL]METHYL]CYCLOHEXYL)METHYL]HEXAHYDRO-1H-4,7-METHANISOINDOL-1,3-DIONE

(3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione

(3aR,4S,7R,7aS)-2-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione

367514-87-2 (free base)

367514-88-3

5-hydroxytryptamine receptor 1A

5-hydroxytryptamine receptor 2A

5-hydroxytryptamine receptor 7

5HT1A_RAT

5HT2A_RAT

5HT7R_HUMAN

CAS_441351-20-8::Lurasidone::SM 13496

D(2) dopamine receptor

D(4) dopamine receptor

DRD2_HUMAN

DRD2_RAT

DRD4_HUMAN

Latuda®

lurasidona

lurasidonum

MFCD14635357

луразидон

لوراسيدون

鲁拉西酮